Latest debt-to-equity ratio
Moleculin Biotech Debt-to-equity ratio
Direct answer
Moleculin Biotech's debt-to-equity ratio is 2.52%.
The verified market snapshot reports 2.52%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 27, 2026.
Get free Moleculin Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.52%
Explore related company data
View Moleculin Biotech's market capitalizationView Moleculin Biotech's p/e ratioView Moleculin Biotech's price-to-book ratioView Moleculin Biotech's return on equityView Moleculin Biotech's 52-week price rangeView Moleculin Biotech's profit marginView all Moleculin Biotech key metricsReturn to Moleculin Biotech profile